home / stock / acxp / acxp short
Short Information | Acurx Pharmaceuticals Inc. (NASDAQ:ACXP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 310,039 |
Total Actual Volume | 1,591,872 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 15,502 |
Average Short Percentage | 19.53% |
Is there a ACXP Short Squeeze or Breakout about to happen?
See the ACXP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $2.48 | $2.32 | $2.49 | $2.16 | 83,577 | 13,871 | 16.6% |
07-19-2024 | $2.65 | $2.43 | $2.75 | $2.35 | 117,697 | 41,085 | 34.91% |
07-18-2024 | $2.87 | $2.54 | $3.325 | $2.5 | 856,891 | 140,792 | 16.43% |
07-17-2024 | $2.66 | $2.62 | $2.66 | $2.46 | 70,514 | 30,159 | 42.77% |
07-16-2024 | $2.45 | $2.47 | $2.56 | $2.38 | 16,642 | 2,254 | 13.54% |
07-15-2024 | $2.47 | $2.39 | $2.47 | $2.37 | 19,361 | 3,930 | 20.3% |
07-12-2024 | $2.38 | $2.31 | $2.565 | $2.27 | 66,948 | 15,050 | 22.48% |
07-11-2024 | $2.29 | $2.3 | $2.4 | $2.26 | 29,269 | 7,455 | 25.47% |
07-10-2024 | $2.08 | $2.21 | $2.3 | $2.06 | 20,222 | 7,050 | 34.86% |
07-09-2024 | $2 | $2.13 | $2.19 | $1.99 | 46,905 | 5,702 | 12.16% |
07-08-2024 | $2.03 | $2.02 | $2.07 | $2.02 | 17,313 | 4,436 | 25.62% |
07-05-2024 | $2.01 | $2.06 | $2.1 | $2.01 | 24,945 | 7,650 | 30.67% |
07-03-2024 | $2.13 | $2.01 | $2.185 | $2.01 | 20,303 | 1,189 | 5.86% |
07-02-2024 | $2.16 | $2.16 | $2.3 | $2.07 | 50,223 | 12,922 | 25.73% |
07-01-2024 | $2.23 | $2.14 | $2.25 | $2.14 | 23,471 | 3,404 | 14.5% |
06-28-2024 | $2.34 | $2.25 | $2.35 | $2.19 | 32,420 | 3,114 | 9.61% |
06-27-2024 | $2.27 | $2.31 | $2.4 | $2.16 | 36,951 | 4,924 | 13.33% |
06-26-2024 | $2.22 | $2.24 | $2.27 | $2.16 | 19,090 | 1,884 | 9.87% |
06-25-2024 | $2.27 | $2.17 | $2.3 | $2.17 | 18,637 | 877 | 4.71% |
06-24-2024 | $2.33 | $2.28 | $2.4 | $2.28 | 20,493 | 2,291 | 11.18% |
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Inc. Website:
USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome PR Newswire STATEN ISLAND, N.Y. , July 17, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ:...
Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , July 16, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference PR Newswire Additional analyses of clinical and microbiological data from the Phase 2b segment show favorable gut microbiome changes including inc...